Adefovir dipivoxil for chronic hepatitis B

To assess the benefits and harms of adefovir dipivoxil alone or in combination with other drugs, as compared with no treatment or placebo in the treatment of patients with chronic hepatitis B virus infection.

This is a protocol.

You may also be interested in:

Adefovir dipivoxil versus other antiviral drugs for chronic hepatitis B
Adefovir dipivoxil for adults with lamivudine-resistant chronic hepatitis B virus infection
Adefovir dipivoxil for chronic hepatitis B
Lamivudine with or without adefovir dipivoxil for postoperative hepatocellular carcinoma
Continued lamivudine for adults with lamivudine-resistant chronic hepatitis B virus infection

Health topics:

Gastroenterology & hepatology > Liver disorders > Hepatitis B

Infectious disease > Liver infections > Hepatitis B

Don't show again

What role do you identify with the most?

Patient or care giver

Health practitioner

Researcher

Policy Maker

We are collecting information on visitors to our website to ensure Cochrane resources meet the needs of our users. Your data will be anonymised for processing, will be stored securely, and will not be shared with any third parties.